[ad_2][ad_1] Rohan Hall, Entrepreneur | Sr. Architect | Emerging Technology Group, Capital Group | American funds Rohan Hall, Entrepreneur | Sr. Architect | Emerging Technology Group, Capital Group | American funds The pharmaceutical industry is a massive, multi-trillion industry and within it there are several regulations that must be met. …
Read More »Blockchain and artificial intelligence to model pharmaceutical transport in 2019 »www.globalcoldchainnews.com
[ad_2][ad_1] Filadelfia, artificial intelligence and external market forces such as the shortage of pilots and sea transport as an alternative to air transport are expected to change the transportation of drugs in 2019 and beyond, says Pelican BioThermal. Dominic Hyde, vice president of Crēdo on Demand at Pelican BioThermal, says …
Read More »The interest of the pharmaceutical industry for the blockchain is increasing, but the interest does not come from suppliers
[ad_2][ad_1] Written by Jessica Kim Cohen December 4, 2018 | <a href = "http://www.beckershospitalreview.com/healthcare-information-technology/healthcare-industry-interest-in-blockchain-is-rising-but-interest-isn-t-coming-from-providers.html ? tmpl = component & print = 1 & layout = default "data-tracking =" print "title =" Print article < Healthcare industry interest in blockchain is rising — but interest isn't coming from providers >"onclick =" …
Read More »How Blockchain will revolutionize the pharmaceutical industry
[ad_2][ad_1]<div _ngcontent-c14 = "" innerhtml = " PexelsPexels Pharmaceuticals are a $ 466 billion industry in the United States, second Statesman.& Nbsp;However, privacy concerns and transparency in clinical trials have the potential to prevent the future of drug development and increase costs. & nbsp; Emerging technologies such as blockchain should …
Read More »In Blockchain We Trust | Pharmaceutical manager
[ad_2][ad_1] What would happen if innovations in the life sciences chain were updated with innovations in drugs and treatments? With many standards of serialization and traceability in the compliance period, and others (for example, FMD UE, US DSCSA) at the horizon, life sciences companies need to think beyond serialization as …
Read More »